Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

7.170 +0.040 (+0.56%)
Official Closing Price Updated: 4:10 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
Organon Easily Beats First-Quarter Expectations Despite Nexplanon Slip-Up ↗
The firm's biggest product sustained a hit due to exchange rates and buying patterns. 
Via Investor's Business Daily
News headline image
Organon Reports Results for the First Quarter Ended March 31, 2022
From Organon & Co.
Via Business Wire
News headline image
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
From Organon & Co.
Via Business Wire
News headline image
Amphastar's Generic Ganirelix Acetate Injection Scores FDA Approval ↗
 
Via Benzinga
News headline image
Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment ↗
Organon & Co (NYSE: OGN)  
Via Benzinga
News headline image
Merck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance ↗
Organon's sales and earnings fell less than expected, but 2022 sales guidance missed. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For February 17, 2022 ↗
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
News headline image
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
From Organon & Co.
Via Business Wire
News headline image
Healthy Pharma Favorites ↗
Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor. 
Via Talk Markets
News headline image
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar ↗
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-... 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
World Markets News For Thursday ↗
Ericsson stock lost another 5.27% today in US markets. 
Via Talk Markets
News headline image
Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B ↗
Organon & Co's (NYSE: OGN) Q4 FY21 sales decreased 1% to $1.6 billion, beating the consensus of $1.57 billion. Women's Health increased 6%, driven primarily... 
Via Benzinga
News headline image
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
From Organon & Co.
Via Business Wire
News headline image
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
From Organon & Co.
Via Business Wire
News headline image
Nuclear Winter ↗
Mexico is raising interest rates to 6%, from 5.5%. 
Via Talk Markets
News headline image
Organon antaa koko henkilökunnalleen vapaapäivän oman terveytensä edistämiseksi kansainvälisenä naisten päivänä
”Koska Covid-19-pandemialla on edelleen suhteettoman suuri vaikutus naisiin, Organon kutsuu muita organisaatioita liittymään joukkoonsa ja olemaan 
Via EIN Presswire
News headline image
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
From Organon & Co.
Via Business Wire
News headline image
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
From Organon & Co.
Via Business Wire
News headline image
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
From Organon & Co.
Via Business Wire
News headline image
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
News headline image
Organon Completes Acquisition of Forendo Pharma
From Organon & Co.
Via Business Wire
News headline image
Warren Buffett Is Selling These Stocks ↗
Looking to make money moves like Warren Buffett? Want to know which stocks Buffett is selling? Interested in finding out why these stock sales might be a huge mistake? 
Via Talk Markets
News headline image
Tuesday Markets Coverage ↗
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears. 
Via Talk Markets
News headline image
Novartis May Have Buyer(s) For Its Sandoz Unit - Report ↗
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG... 
Via Benzinga
News headline image
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
From Organon & Co.
Via Business Wire
News headline image
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio ↗
Spin-off stocks can be lucrative for shareholders in both legacy businesses and recently created public companies. Here are three to know. 
Via InvestorPlace
News headline image
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3 ↗
Warren Buffett's Berkshire Hathaway Inc (NYSE: BRK-A) cleared its stake in Merck & Co Inc (NYSE: MRK) in Q3, right on the eve of a significant stock... 
Via Benzinga
News headline image
Warren Buffet Takes A Stake In Royalty Pharma And Exits Merck — What You Need To Know ↗
Warren Buffet's Berkshire Hathaway added more than 13 million shares. 
Via Investor's Business Daily
News headline image
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care ↗
Johnson & Johnson will split its consumer health unit into a publicly traded company. 
Via Investor's Business Daily
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.